ANIX Reports Encouraging Survival Rates in Ovarian Cancer CAR-T Trial; Achieves Regulatory Approval for Dose Escalation Up to 100x Higher
Anixa Biosciences, Inc. · PHARMACEUTICAL PREPARATIONS · Now $2.70
Post-detection moves
1h
—
1d
—
3d
—
7d
—
30d
—
Get alerts like this in real time
Push notifications the moment a signal fires. No spam, no crypto, no fluff.
Download for iOS